Ergoteles LLC - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 92 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$9,938
-94.5%
57,747
-73.0%
0.00%
-100.0%
Q2 2022$182,000
-37.9%
213,613
+604.7%
0.01%
-54.5%
Q4 2021$293,000
+337.3%
30,314
+126.1%
0.01%
+22.2%
Q3 2020$67,00013,4070.01%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders